Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mousumi Shyam

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
ACS Infectious Diseases|January 31, 2024
Unlocking Opportunities for <i>Mycobacterium leprae</i> and <i>Mycobacterium ulcerans</i>Mousumi Shyam, Sumit Kumar, Vinayak Singh
Expert Opinion on Drug Discovery|May 16, 2022
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we standMousumi Shyam, Deepak Shilkar, Gourav Rakshit, et al.
Mini Reviews in Medicinal Chemistry|March 5, 2019
Scaffold Based Search on the Desferithiocin ArchetypeMousumi Shyam, Abhimanyu Dev, Barij Nayan Sinha, et al.
Frontiers in Antibiotics|January 16, 2025
Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assaysMousumi Shyam, Abhishek Thakur, Caroline Velez, et al.
Journal of Medicinal Chemistry|December 29, 2020
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against TuberculosisMousumi Shyam, Deepak Shilkar, Harshita Verma, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial AntibioticsMousumi Shyam, Gourab Bhattacharje, Chris Daniel, et al.
Journal of Medicinal Chemistry|January 4, 2022
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump InhibitionMousumi Shyam, Harshita Verma, Gourab Bhattacharje, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
ACS Infectious Diseases|January 31, 2024
Unlocking Opportunities for <i>Mycobacterium leprae</i> and <i>Mycobacterium ulcerans</i>Mousumi Shyam, Sumit Kumar, Vinayak Singh
Expert Opinion on Drug Discovery|May 16, 2022
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we standMousumi Shyam, Deepak Shilkar, Gourav Rakshit, et al.
Mini Reviews in Medicinal Chemistry|March 5, 2019
Scaffold Based Search on the Desferithiocin ArchetypeMousumi Shyam, Abhimanyu Dev, Barij Nayan Sinha, et al.
Frontiers in Antibiotics|January 16, 2025
Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assaysMousumi Shyam, Abhishek Thakur, Caroline Velez, et al.
Journal of Medicinal Chemistry|December 29, 2020
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against TuberculosisMousumi Shyam, Deepak Shilkar, Harshita Verma, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial AntibioticsMousumi Shyam, Gourab Bhattacharje, Chris Daniel, et al.
Journal of Medicinal Chemistry|January 4, 2022
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump InhibitionMousumi Shyam, Harshita Verma, Gourab Bhattacharje, et al.
Pageof 1